Outbreak of Salmonella Newport Infections with Decreased Susceptibility to Azithromycin Linked to Beef Obtained in the United States and Soft Cheese Obtained in Mexico --- United States, 2018-2019
This report summarizes an investigation of a multistate multidrug resistant Salmonella outbreak in Mexico and the United States. (Source: CDC Morbidity and Mortality Weekly Report)
Source: CDC Morbidity and Mortality Weekly Report - August 22, 2019 Category: American Health Tags: Antibiotic Use, Appropriate MMWR Morbidity & Mortality Weekly Report Salmonella Source Type: news
Private Rooms Help Sustain Lower Rates of Some Nosocomial Colonization
WEDNESDAY, Aug. 21, 2019 -- A hospital ' s move to entirely single-patient rooms was associated with reductions in multidrug-resistant organism colonization, according to a study published online Aug. 19 in JAMA Internal Medicine.
Emily G. McDonald,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 21, 2019 Category: Pharmaceuticals Source Type: news
FDA approves pretomanid tablets in combination with bedaquiline and linezolid for treatment of extensively drug resistant, treatment-intolerant or nonresponsive multidrug resistant pulmonary TB
Pretomanid is a new chemical entity and a member of a class of compounds known as nitroimidazooxazines. A successful outcome has been reported in 95 of the first 107 patients in trial after six months of treatment with this regimen and six months of post-treatment follow-up. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 16, 2019 Category: Consumer Health News Source Type: news
First New Tuberculosis Drug Approved in 50 Years
The US Food and Drug Administration green lights a therapy for an extreme form of multidrug resistant TB. (Source: The Scientist)
Source: The Scientist - August 15, 2019 Category: Science Tags: News & Opinion Source Type: news
Janssen Announces U.S. FDA Accelerated Approval for SIRTURO ® (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis
(Source: Johnson and Johnson)
Source: Johnson and Johnson - August 9, 2019 Category: Pharmaceuticals Source Type: news
Janssen Announces U.S. FDA Accelerated Approval for Sirturo (bedaquiline) as Part of Combination Therapy to Treat Adolescents with Pulmonary Multidrug-Resistant Tuberculosis
TITUSVILLE, NJ, August 9, 2019— The Janssen Pharmaceutical Companies of Johnson& Johnson today announced that the U.S. Food and Drug Administration (FDA) has granted approval for Sirturo (bedaquiline) tablets as part of combination... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 9, 2019 Category: Drugs & Pharmacology Source Type: news
Superbugs Found Lurking in London Underground and Hospitals Superbugs Found Lurking in London Underground and Hospitals
Scientists have found multidrug-resistant"superbug" bacteria lurking on cash machines, escalators and handrails in London ' s underground rail system, shopping centers and hospitals and say they pose a potential risk to public health.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 6, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Superbugs found lurking in London underground and hospitals
Scientists have found multidrug-resistant "superbug" bacteria lurking on cash machines, escalators and handrails in London's underground rail system, shopping centres and hospitals and say they pose a potential risk to public health. (Source: Reuters: Health)
Source: Reuters: Health - August 1, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
EMA Panel Recommends Ibalizumab for Multidrug-Resistant HIV-1 EMA Panel Recommends Ibalizumab for Multidrug-Resistant HIV-1
A European Medicines Agency advisory panel recommended marketing authorization for ibalizumab (Trogarzo, Theratechnologies International) for the treatment of patients with multidrug-resistant HIV-1 infection.International Approvals (Source: Medscape Med Students Headlines)
Source: Medscape Med Students Headlines - July 29, 2019 Category: Universities & Medical Training Tags: HIV/AIDS News Alert Source Type: news
Future Challenges in Pediatric and Neonatal Sepsis: Emerging Pathogens and Antimicrobial Resistance
The incidence of severe infections caused by multidrug-resistant (MDR) pathogens is currently rising worldwide, and increasing numbers of neonates and children with serious bloodstream infections due to resistant bacteria are being reported. Severe sepsis and septic shock due to gram-negative bacteria represent a significant cause of morbidity and mortality, and contribute to high health care costs. Antimicrobial resistance among Enterobacteriaceae represents a major problem in both health care-associated and community-acquired infections, with extended-spectrum β-lactamases (ESBLs) and carbapenem-resistant Enterobacteria...
Source: Current Awareness Service for Health (CASH) - July 24, 2019 Category: Consumer Health News Source Type: news
Multidrug-Resistant Malaria Spreading in Southeast Asia -Study Multidrug-Resistant Malaria Spreading in Southeast Asia -Study
Malaria parasites resistant to two key anti-malarial medicines are becoming more dominant in Vietnam, Laos and northern Thailand after spreading rapidly from Cambodia, scientists warned on Monday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - July 23, 2019 Category: Consumer Health News Tags: Infectious Diseases News Source Type: news
Multidrug-resistant malaria spreading in Southeast Asia: study
Strains of malaria resistant to two key anti-malarial medicines are becoming more dominant in Vietnam, Laos and northern Thailand after spreading rapidly from Cambodia, scientists warned on Monday. (Source: Reuters: Health)
Source: Reuters: Health - July 22, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
The Lancet Infectious Diseases: Rapidly spreading multidrug-resistant parasites render frontline malaria drug ineffective in southeast Asia
(The Lancet) Multidrug-resistant forms of Plasmodium falciparum parasites, the most lethal species causing human malaria, have evolved even higher levels of resistance to antimalarial drugs and spread rapidly since 2015, becoming firmly established in multiple regions of Cambodia, Laos, Thailand, and Vietnam, where they are causing alarmingly high treatment failure rates to a widely used frontline malaria drug combination. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - July 22, 2019 Category: Infectious Diseases Source Type: news
Multidrug-resistant malaria spreading in Asia
(Wellcome Trust Sanger Institute) Genomic surveillance has revealed that malaria resistance to two first-line antimalarial drugs has spread rapidly from Cambodia to neighboring countries in Southeast Asia. Researchers discovered that descendants of one multi-drug resistant malaria strain are replacing the local parasites in Vietnam, Laos and northeastern Thailand, and are picking up additional new genetic changes which could further enhance resistance. The study in The Lancet Infectious Diseases reveals the importance of ongoing genomic surveillance in malaria control strategies. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - July 22, 2019 Category: Biology Source Type: news
Current Antibiotic Stewardship Program Practices Characterized
FRIDAY, July 19, 2019 -- Current infection prevention and antibiotic stewardship program practices continue to include a main focus on surveillance for multidrug-resistant organisms, according to a report published online July 17 in Infection... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 19, 2019 Category: Pharmaceuticals Source Type: news
